HLB bioStep Co.,Ltd. (KOSDAQ:A278650) announces a share repurchase program. Under the program, the company will repurchase up to KRW 3,000 million worth of its shares pursuant to a trust contract with Samsung Securities Co., Ltd. The purpose of the share repurchase is to stabilizing stock prices and improving shareholder value. The repurchase program will expire on May 21, 2025.

As of May 19, 2024, the company had 1,173,542 shares within scope available for dividend and had no shares in treasury through other repurchase.